Clinical Trial Update: A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SHR1701 with radiotherapy in metastatic non-small cell lung cancer after failure of first-line treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR1701

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: UNKNOWN